Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistance

CAS OpenIR > 2024年度论文

	Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistance
发表期刊	NATURE CANCER
	2024-02
卷号	5 期号:2 页码:211-215
	Zheng, Hao; Liu, Jinming; Cheng, Qi; Zhang, Qianping; Zhang, Yaoyao; Jiang, Lingyu; Huang, Yan; Li, Wenlei; Zhao, Yanping; Chen, Guo; Yu, Fan; Liu, Lei; Li, Yanjun; Liao, Xudong; Xu, Lai; Xiao, Yi; Zheng, Zhibo; Li, Ming; Wang, Hongyi; Hu, Gang; Du, Lei; Chen, Quan
关键词	STEM-CELLS BETA-CATENIN WNT COLON GPX4 HETEROGENEITY ESTABLISHMENT EXPRESSION CD44
文献类型	期刊论文
条目标识符	http://ir.ioz.ac.cn/handle/000000/15859
专题	2024年度论文
推荐引用方式 GB/T 7714	Zheng, Hao,Liu, Jinming,Cheng, Qi,et al. Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistance[J]. NATURE CANCER,2024,5(2):211-215.
APA	Zheng, Hao.,Liu, Jinming.,Cheng, Qi.,Zhang, Qianping.,Zhang, Yaoyao.,...&Chen, Quan.(2024).Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistance.NATURE CANCER,5(2),211-215.
MLA	Zheng, Hao,et al."Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistance".NATURE CANCER 5.2(2024):211-215.